Q4FY22, the company garnered a gross premium of ₹3,689.15 crore up from ₹2,704.54 crore in Q3FY22 and ₹3,261.82 crore in Q4FY21.
Net premium jumped to ₹3,473.77 crore against ₹2,556.82 crore in Q3FY22 and ₹2,620.44 crore in Q4FY22. The company's premium earned was robust at ₹2,621.17 crore in Q4FY22 against ₹663.82 crore in Q4FY21.
Ansuman Deb and Ravin Kurwa Research Analysts at ICICI Direct in their research note said, "Star Health is the leading health insurance player in India with 15%/33% market share in total/retail health insurance as of FY22 based on GDPI data provided by General Insurance council.
A strong network of 0.55mn agents, 12,820 hospitals, and 807 branches in FY22 makes STAR the dominant franchise in Indian health insurance with significant entry barriers." This is further complemented by healthy financials (18% PAT CAGR over FY16-FY20 and average RoE of 15.5% over FY18-FY20) and strong management, the duo added in their note.